Detailed information for compound 183128

Basic information

Technical information
  • TDR Targets ID: 183128
  • Name: 3-(6-aminopyridin-3-yl)-N-methyl-N-[(1-methyl indol-2-yl)methyl]propanamide
  • MW: 322.404 | Formula: C19H22N4O
  • H donors: 1 H acceptors: 2 LogP: 1.8 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: Nc1ccc(cn1)CCC(=O)N(Cc1cc2c(n1C)cccc2)C
  • InChi: 1S/C19H22N4O/c1-22(19(24)10-8-14-7-9-18(20)21-12-14)13-16-11-15-5-3-4-6-17(15)23(16)2/h3-7,9,11-12H,8,10,13H2,1-2H3,(H2,20,21)
  • InChiKey: CAEFFYSYRJMIGG-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 3-(6-amino-3-pyridyl)-N-methyl-N-[(1-methylindol-2-yl)methyl]propanamide
  • 3-(6-amino-3-pyridyl)-N-methyl-N-[(1-methyl-2-indolyl)methyl]propanamide
  • 3-(6-azanylpyridin-3-yl)-N-methyl-N-[(1-methylindol-2-yl)methyl]propanamide
  • 3-(6-amino-3-pyridyl)-N-methyl-N-[(1-methylindol-2-yl)methyl]propionamide
  • aminopyridine deriv. 11

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Onchocerca volvulus Bile acid receptor homolog 0.0363 0 0.5
Schistosoma mansoni retinoic acid receptor RXR 0.1403 1 0.5
Echinococcus multilocularis retinoic acid receptor rxr beta a retinoic acid receptor rxr alpha a retinoic acid receptor rxr alpha 0.1246 0.8492 0.5
Loa Loa (eye worm) hypothetical protein 0.0363 0 0.5
Brugia malayi ecdysteroid receptor 0.0363 0 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) > 30 uM Inhibition of Enoyl-ACP reductase from S. pneumoniae ChEMBL. 12109908
IC50 (binding) > 30 uM Inhibition of Enoyl-ACP reductase from S. pneumoniae ChEMBL. 12109908
IC50 (binding) = 93.7 uM Concentration of the compound required for the 50% inhibition of enoyl-ACP reductase from S. aureus was determined. ChEMBL. 12109908
IC50 (binding) = 93.7000000000001 uM Concentration of the compound required for the 50% inhibition of enoyl-ACP reductase from S. aureus was determined. ChEMBL. 12109908
IC50 (binding) = 97.4 uM Concentration of the compound required for the 50% inhibition of enoyl-ACP reductase from H. influenzae was determined. ChEMBL. 12109908
MIC (functional) > 64 ug ml-1 Minimum concentration of the compound required for inhibition of S. aureus was determined. ChEMBL. 12109908
MIC (functional) > 64 ug ml-1 Minimum concentration of the compound required for inhibition of H. influenzae was determined. ChEMBL. 12109908
MIC (functional) > 64 ug ml-1 Minimum concentration of the compound required for inhibition of E. faecalis was determined. ChEMBL. 12109908
MIC (functional) > 64 ug ml-1 Minimum concentration of the compound required for inhibition of S. pneumoniae was determined. ChEMBL. 12109908

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.